| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 65 |
| 1 | MYCOPHENOLATE MOFETIL | 63 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 63 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 |
| 4 | TACROLIMUS OINTMENT 0.1% | 61 |
| 5 | RUXOLITINIB | 60 |
| 6 | CYCLOSPORINE | 58 |
| 7 | PREDNISONE | 48 |
| 8 | FLUDARABINE PHOSPHATE | 43 |
| 9 | METHOTREXATE SODIUM | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELUMOSUDIL | 25 | 0.0074 |
| 1 | PENICILLIN V POTASSIUM | 7 | 0.0027 |
| 2 | THIOTEPA | 18 | 0.0018 |
| 3 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 4 | 0.0016 |
| 4 | BUSULFAN | 20 | 0.0013 |
| 5 | MARIBAVIR | 3 | 0.0012 |
| 6 | NALOXONE HCL | 1 | 0.0012 |
| 7 | GLOFITAMAB | 3 | 0.0011 |
| 8 | TREOSULFAN | 3 | 0.0011 |
| 9 | FLUDARABINE PHOSPHATE | 43 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 4 | 0.0016 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 3 | 0.0012 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 4 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 58 | 0.0004 |
| 6 | Janus Kinase Inhibitor [EPC] | 60 | 0.0004 |
| 7 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Bile Acid [EPC] | 7 | 0.0003 |